Exicure, Inc. ( XCUR) - Key Metrics
XCUR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.18 | -$0.14 | -$0.14 |
| 2026Q1 | $0 | -$0.29 | -$0.18 | -$0.18 |
| 2025Q4 | $0 | -$0.46 | -$0.18 | -$0.15 |
| 2025Q3 | $0 | -$0.39 | -$0.56 | -$0.54 |
| 2025Q2 | $0 | -$0.41 | -$0.36 | -$0.41 |
XCUR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.89 |
| 2026Q1 | 0% | -3.66 |
| 2025Q4 | -2.73% | -3.01 |
| 2025Q3 | 0% | -2.62 |
| 2025Q2 | 0% | -4.29 |
XCUR
Price: $1.43
52 week price:
Earnings Per Share: -1.57 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 9300
Market Capitalization: 8.0 million